Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001013762-21-000108
Filing Date
2021-10-04
Accepted
2021-10-04 17:05:24
Documents
7
Effectiveness Date
2021-10-04

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea147925-s8_celularityinc.htm S-8 82779
2 OPINION OF GOODWIN PROCTER LLP ea147925ex5-1_celularity.htm EX-5.1 5368
3 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ea147925ex23-1_celularity.htm EX-23.1 2117
4 CONSENT OF DELOITTE & TOUCHE LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ea147925ex23-2_celularity.htm EX-23.2 1174
5 CELULARITY INC. 2021 EQUITY INCENTIVE PLAN ea147925ex99-3_celularity.htm EX-99.3 198462
6 FORMS OF STOCK OPTION GRANT NOTICE, OPTION AGREEMENT, NOTICE OF EXERCISE, RSU AW ea147925ex99-4_celularity.htm EX-99.4 105696
7 CELULARITY INC. 2021 EMPLOYEE STOCK PURCHASE PLAN ea147925ex99-5_celularity.htm EX-99.5 67848
  Complete submission text file 0001013762-21-000108.txt   464559
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-260025 | Film No.: 211303762
SIC: 2834 Pharmaceutical Preparations